C12Y 301/03001
Alkaline phosphatase
Official title: Alkaline phosphatase (3.1.3.1)
C12Y301/03001 (Alkaline phosphatase) appears on 154 US grants and 279 published applications in this corpus.
Search patents in C12Y- Granted patents
- 154
- Published applications
- 279
- Assignees
- 155
- Inventors
- 521
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 5 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 2 |
| 2004 | 1 | 3 |
| 2005 | 1 | 4 |
| 2006 | 3 | 2 |
| 2007 | 2 | 9 |
| 2008 | 1 | 4 |
| 2009 | 2 | 6 |
| 2010 | 5 | 11 |
| 2011 | 4 | 7 |
| 2012 | 2 | 3 |
| 2013 | 6 | 9 |
| 2014 | 6 | 8 |
| 2015 | 2 | 5 |
| 2016 | 5 | 18 |
| 2017 | 3 | 19 |
| 2018 | 12 | 12 |
| 2019 | 9 | 18 |
| 2020 | 11 | 21 |
| 2021 | 13 | 20 |
| 2022 | 15 | 19 |
| 2023 | 12 | 15 |
| 2024 | 12 | 20 |
| 2025 | 10 | 25 |
| 2026 | 5 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Alkaline phosphatase formulations and uses thereof28 Jul 2026US 12,691,077 B2Theriva Biologics, Inc.
- Alkaline phosphatase agents for treatment of radiation disorders9 Jun 2026US 12,648,987 B2Theriva Biologics, Inc.
- Methods for treating bone mineralization disorders28 Apr 2026US 12,611,447 B2Alexion Pharmaceuticals, Inc.
- Compositions and methods for enzyme immobilization21 Apr 2026US 12,606,813 B2AgroSpheres, Inc.
- Chimeric alkaline phosphatase-like proteins27 Jan 2026US 12,534,713 B2AM-Pharma B.V.
- Treating muscle weakness with alkaline phosphatases8 Oct 2026US 2026/0306590 A1
- Alkaline phosphatase for use in treating acute-on-chronic kidney injury17 Sep 2026US 2026/0275308 A1
- Method of treating cid by phe-iap, iap-trp, and phe-iap-trp complexes3 Sep 2026US 2026/0256894 A1
- Srna derived from medicinal plant and application thereof20 Aug 2026US 2026/0242799 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Derivatives, immunogens, and antibodies and use of the same in detection of ecstasy-class compounds13 Aug 2026US 2026/0234121 A1Siemens Healthcare Diagnostics Inc.
Most cited
By later US patents
- Three-dimensional polymer matrices268US 6,471,993 B1Massachusetts Institute of Technology · 2002
- Production of enzymes having desired activities by mutagenesis204US 5,939,250 ADiversa Corporation · 1999
- Modified polynucleotides for reducing off-target effects in RNA interference144US 7,595,387 B2Dharmacon, Inc. · 2009
- Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same130US 5,681,811 AProtein Delivery, Inc. · 1997
- Method for screening for enzyme activity127US 6,054,267 ADiversa Corporation · 2000